Genes, dreams, and cancer
1Royal Postgraduate Medical School, Hammersmith Hospital, London.
Abstract:
There have been tremendous advances in our understanding of cancer from the application of molecular biology over the past decade. The disease is caused by a series of defects in the genes that accelerate growth--oncogenes--and those that slow down cellular turnover--tumour suppressor genes. The proteins they encode provide a promising hunting ground in which to design and test new anticancer drugs. Several treatment strategies are now under clinical trial entailing direct gene transfer. These include the use of gene marking to detect minimal residual disease, the production of novel cancer vaccines by the insertion of genes which uncloak cancer cells so making them visible to the host's immune system, the isolation and coupling of cancer specific molecular switches upstream of drug activating genes, and the correction of aberrant oncogenes or tumour suppressor genes. The issues in these approaches are likely to have a profound impact on the management of cancer patients as we enter the next century.
Insights
Molecular biology advances cancer understanding, revealing gene defects driving tumor growth. Gene transfer therapies show promise for cancer vaccines and targeted drug delivery, impacting future patient management.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer arises from genetic defects in oncogenes and tumor suppressor genes.
- Proteins encoded by these genes are key targets for novel anticancer drug development.
- Molecular biology has revolutionized cancer research and therapeutic strategies over the past decade.
Purpose of the Study:
- To explore the impact of molecular biology on cancer understanding.
- To review emerging gene transfer-based cancer treatment strategies.
- To discuss the future implications of these advancements in cancer patient management.
Main Methods:
- Review of recent advances in cancer molecular biology.
- Analysis of gene transfer-based therapeutic approaches currently in clinical trials.
- Discussion of the potential of targeting oncogenes and tumor suppressor genes.
Main Results:
- Identification of specific gene defects (oncogenes, tumor suppressor genes) as fundamental to cancer development.
- Emergence of direct gene transfer as a promising therapeutic modality.
- Development of diverse gene transfer strategies including gene marking, cancer vaccines, targeted gene activation, and gene correction.
Conclusions:
- Molecular biology has significantly advanced cancer understanding and drug development.
- Gene transfer therapies offer novel treatment avenues with potential to transform cancer management.
- Future cancer care will likely be profoundly influenced by these molecularly targeted approaches.
Related Concept Videos
02:18Cancer
02:12What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:12What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:06Induced Pluripotent Stem Cells
Somatic cells are...